CC
Casdin Capital Portfolio holdings
AUM
$1.1B
This Quarter Return
+23.9%
1 Year Return
+24.98%
3 Year Return
+152.8%
5 Year Return
+110.01%
10 Year Return
–
AUM
$409M
AUM Growth
+$409M
(+16%)
Cap. Flow
+$28.6M
Cap. Flow
% of AUM
6.98%
Top 10 Holdings %
Top 10 Hldgs %
66%
Holding
28
New
2
Increased
13
Reduced
1
Closed
2
Top Buys
| 1 |
Fate Therapeutics
FATE
|
$12.5M |
| 2 |
GBT
Global Blood Therapeutics, Inc.
GBT
|
$5.31M |
| 3 |
Voyager Therapeutics
VYGR
|
$5.31M |
| 4 |
GNMK
GenMark Diagnostics, Inc
GNMK
|
$5.13M |
| 5 |
ONCE
Spark Therapeutics, Inc. Common Stock
ONCE
|
$4.78M |
Top Sells
| 1 |
KITE
Kite Pharma, Inc.
KITE
|
$19.1M |
| 2 |
TSRO
TESARO, Inc.
TSRO
|
$4.97M |
| 3 |
Ovid Therapeutics
OVID
|
$469K |
Sector Composition
| 1 | Healthcare | 93.42% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
26
Ovid Therapeutics
OVID
$91M
| $1.58M | 0.38% |
160,000
-47,500
| -23% | -$469K |
|
|
TSRO
27
DELISTED
TESARO, Inc.
TSRO
| – | – |
-38,500
| Closed | -$4.97M |
|
|
KITE
28
DELISTED
Kite Pharma, Inc.
KITE
| – | – |
-106,000
| Closed | -$19.1M |
|